TABLE 1.
Pathogenicity of GBS with one- or nine-repeat alpha C protein in immune and nonimmune micea
| Challenge strain | LD50 after immunization with:
|
||
|---|---|---|---|
| One-repeat antiserum | Nine-repeat antiserum | Preimmune antiserum | |
| One-repeat A909 | 5.5 × 104 | 1.6 × 103 | 1.0 × 103 |
| Nine-repeat A909 | 2.4 × 105 | 1.8 × 105 | 2.4 × 103 |
| P value | 0.3842 | 0.0073b | 0.5813 |
LD50s were calculated by using the logistic regression procedure. Mice were immunized with rabbit antiserum elicited to one- or nine-repeat alpha C protein. Pups were challenged with 0.05 ml intraperitoneally within 48 h of birth. The range of the challenge dose was 5 × 102 to 5 × 107/mouse. Survival was determined 48 h after challenge.
Significant difference between LD50s of GBS with one- and nine-repeat alpha C proteins.